Cargando…

Discontinuation Rate of Newly Prescribed Donepezil in Alzheimer's Disease Patients in Asia

BACKGROUND AND PURPOSE: The rate of donepezil discontinuation and the underlying reasons for discontinuation in Asian patients with Alzheimer's disease (AD) are currently unknown. We aimed to determine the treatment discontinuation rates in AD patients who had newly been prescribed donepezil in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Kee Hyung, Yang, YoungSoon, Chen, Christopher, Shim, Yong S., Domingueze, Jacqueline C., Lee, Chan-Nyoung, Kang, Kyunghun, Kim, Hee-Jin, Jeong, Seul-Ki, Jeong, Jee Hyang, Hong, Zhen, Yoon, Soo Jin, Zhang, Zhen-Xin, Kim, Eun-Joo, Jang, Jae-Won, Li, Yansheng, Xu, Yun, Lin, Yu-Te, Qu, Qiumin, Hu, Chaur-Jong, Chou, Chih-Ho, Fan, Dongsheng, Kandiah, Nagaendran, Yang, Yuan-Han, Lau, Chi-ieong, Chu, Leung-Wing, Wang, Huali, Jung, San, Choi, Seong Hye, Kim, SangYun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242303/ https://www.ncbi.nlm.nih.gov/pubmed/34184445 http://dx.doi.org/10.3988/jcn.2021.17.3.376

Ejemplares similares

Impact of an Education Program for Caregivers of Patients with Alzheimer's Disease on Treatment Discontinuation and Compliance in Korea
por: Kim, Hee-Jin, et al.
Publicado: (2021)

Clinical Aspects of Neurobehavioral Symptoms of Dementia
por: Yang, YoungSoon, et al.
Publicado: (2020)

Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific Region
por: Sabbagh, Marwan, et al.
Publicado: (2016)

Safety and tolerability of donepezil 23 mg with or without intermediate dose titration in patients with Alzheimer’s disease taking donepezil 10 mg: a multicenter, randomized, open-label, parallel-design, three-arm, prospective trial
por: Hong, Yun Jeong, et al.
Publicado: (2019)

Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer’s disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial
por: Koh, Seong-Ho, et al.
Publicado: (2021)

Ischemic Evidence of Transient Global Amnesia: Location of the Lesion in the Hippocampus
por: Yang, YoungSoon, et al.
Publicado: (2008)

The Effects of Donepezil on 15-Item Geriatric Depression Scale Structure in Patients with Alzheimer Disease
por: Yang, Youngsoon, et al.
Publicado: (2016)

Donepezil ameliorates Aβ pathology but not tau pathology in 5xFAD mice
por: Choi, Hee-Jeong, et al.
Publicado: (2022)

Akinetic Mutism and Cognitive-Affective Syndrome Caused by Unilateral PICA Infarction
por: Yang, YoungSoon, et al.
Publicado: (2007)

PSEN2 Thr421Met Mutation in a Patient with Early Onset Alzheimer’s Disease
por: Yang, YoungSoon, et al.
Publicado: (2022)

Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure
por: Yang, YoungSoon, et al.
Publicado: (2018)

Erratum: Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure
por: Yang, YoungSoon, et al.
Publicado: (2023)

Donepezil for mild cognitive impairment in Parkinson’s disease
por: Baik, Kyoungwon, et al.
Publicado: (2021)

Reflections of Two Parallel Pathways between the Hippocampus and Neocortex in Transient Global Amnesia: A Cross-Sectional Study Using DWI and SPECT
por: Park, Young Ho, et al.
Publicado: (2013)

Current and Future Trends in Biomarkers for the Early Detection of Alzheimer’s Disease in Asia: Expert Opinion
por: Kandiah, Nagaendran, et al.
Publicado: (2022)

DW2009 Elevates the Efficacy of Donepezil against Cognitive Impairment in Mice
por: Lee, Dong-Yun, et al.
Publicado: (2021)

Donepezil Regulates LPS and Aβ-Stimulated Neuroinflammation through MAPK/NLRP3 Inflammasome/STAT3 Signaling
por: Kim, Jieun, et al.
Publicado: (2021)

Pharmacokinetic Evaluation of a Novel Donepezil-Loaded Dissolving Microneedle Patch in Rats
por: Rehman, Naveed Ur, et al.
Publicado: (2021)

Cerebellar Hypoperfusion during Transient Global Amnesia: An MRI and Oculographic Study
por: Yang, YoungSoon, et al.
Publicado: (2009)

Rapid and sustained cognitive recovery in APP/PS1 transgenic mice by co-administration of EPPS and donepezil
por: Kim, Hye Yun, et al.
Publicado: (2016)

The Effect of Choline Acetyltransferase Genotype on Donepezil Treatment Response in Patients with Alzheimer’s Disease
por: Lee, Kang Uk, et al.
Publicado: (2015)

Increased Hippocampal-Inferior Temporal Gyrus White Matter Connectivity following Donepezil Treatment in Patients with Early Alzheimer’s Disease: A Diffusion Tensor Probabilistic Tractography Study
por: Kim, Gwang-Won, et al.
Publicado: (2023)

Single dose pharmacokinetics of the novel transdermal donepezil patch in healthy volunteers
por: Kim, Yo Han, et al.
Publicado: (2015)

Donepezil Adherence, Persistence and Time to First Discontinuation in a Three-Year Follow-Up of Older People
por: Ndukwe, Henry C., et al.
Publicado: (2015)

Caregiving, care burden and awareness of caregivers and patients with dementia in Asian locations: a secondary analysis
por: Shim, Yong S., et al.
Publicado: (2021)

A Multicentre, Randomised, Open-Label, Prospective Study to Estimate the Add-On Effects Of Memantine as Ebixa(®) Oral Pump (Solution) on Language in Patients with Moderate to Severe Alzheimer’s Disease Already Receiving Donepezil (ROMEO-AD)
por: Kim, Hee-Jin, et al.
Publicado: (2023)

Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: the CoSCo prospective cohort study
por: Hong, Yun Jeong, et al.
Publicado: (2023)

Longitudinal Cerebral Perfusion Change in Transient Global Amnesia Related to Left Posterior Medial Network Disruption
por: Jang, Jae-Won, et al.
Publicado: (2015)

Novel prion mutation (p.Tyr225Cys) in a Korean patient with atypical Creutzfeldt–Jakob disease
por: Bagyinszky, Eva, et al.
Publicado: (2019)

Model-Based Equivalent Dose Optimization to Develop New Donepezil Patch Formulation
por: Jung, Woojin, et al.
Publicado: (2022)

In Vitro Metabolism of Donepezil in Liver Microsomes Using Non-Targeted Metabolomics
por: Kim, Sin-Eun, et al.
Publicado: (2021)

The Effects of Donepezil, an Acetylcholinesterase Inhibitor, on Impaired Learning and Memory in Rodents
por: Shin, Chang Yell, et al.
Publicado: (2018)

PM381. Reason for clozapine discontinuation
por: Cho, Jin-Woo, et al.
Publicado: (2016)

Predictive Scale for Amyloid PET Positivity Based on Clinical and MRI Variables in Patients with Amnestic Mild Cognitive Impairment
por: Chun, Min Young, et al.
Publicado: (2022)

A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial for Efficacy of Acetyl-L-carnitine in Patients with Dementia Associated with Cerebrovascular Disease
por: Yang, YoungSoon, et al.
Publicado: (2018)

Relationships between 24-Hour Blood Pressures, Subcortical Ischemic Lesions, and Cognitive Impairment
por: Kim, Jung Eun, et al.
Publicado: (2009)

Study Design and Baseline Results in a Cohort Study to Identify Predictors for the Clinical Progression to Mild Cognitive Impairment or Dementia From Subjective Cognitive Decline (CoSCo) Study
por: Ho, SeongHee, et al.
Publicado: (2022)

PET Evidence of the Effect of Donepezil on Cognitive Performance in an Animal Model of Chemobrain
por: Lim, Ilhan, et al.
Publicado: (2016)

Effect of Psychoeducational Intervention on Donepezil Retention Rate and Analysis of Reasons for the Discontinuation in Patients with Alzheimer’s Dementia: A Randomized Study
por: Kamei, Tetsumasa, et al.
Publicado: (2021)

Donepezil-related inadequate neuromuscular blockade during laparoscopic surgery: A case report
por: Jang, Eun-A, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qtpg5gi4lbtdqh0e18aclubpbh